Vishal Chatrath, Co-Founder and CEO of QuantrolOx, to Speak at IQT Quantum & AI Conference in NYC on October 29-30 – Inside Quantum Technology

**Vishal Chatrath, Co-Founder and CEO of QuantrolOx, to Speak at IQT Quantum & AI Conference in NYC on October 29-30...

**The Challenges of Packing This Geometric Shape | Quanta Magazine** In the realm of mathematics and physics, the study of...

**The Challenges of Efficiently Packing This Geometric Shape** In the realm of mathematics and physics, the problem of efficiently packing...

**Interview with Catherine Phipps: The Thrill of Contributing to Aircraft Engine Design – Physics World** In the ever-evolving world of...

**Research on Mitigating Tokamak Plasma Disruptions Wins Plasma Physics and Controlled Fusion Outstanding Paper Prize – Physics World** In a...

**Research on Mitigating Tokamak Plasma Disruption Wins Plasma Physics and Controlled Fusion Outstanding Paper Prize – Physics World** In a...

**Sandia Labs and Boston University Challenge Conventional Wisdom on Speed in Quantum vs. Classical High-Performance Computing – An Analysis by...

**Shapeshifting Organism Utilizes ‘Cellular Origami’ to Expand to 30 Times Its Original Length – Physics World** In a groundbreaking discovery...

**Shapeshifting Organism Utilizes ‘Cellular Origami’ to Expand Up to 30 Times Its Original Length – Physics World** In a groundbreaking...

**Shapeshifting Organism Utilizes ‘Cellular Origami’ to Extend Body Length by 30 Times – Physics World** In the ever-evolving realm of...

**The Impact of AI on Protein Science: Advancements and Ongoing Challenges** In recent years, the intersection of artificial intelligence (AI)...

**IQT Research Projects Quantum Key Distribution Equipment Revenues to Reach $2.3 Billion by 2031 – Inside Quantum Technology Report** In...

**The Global Uranium Craze: Historical Accounts of a Controversial Element** Uranium, a heavy metal with the symbol U and atomic...

**The Global Fascination with Uranium: Historical Accounts of a Controversial Element** Uranium, a heavy metal with the atomic number 92,...

**The Potential Impact of Quantum Batteries on Global Energy Systems** In the quest for sustainable and efficient energy solutions, quantum...

**The Potential Global Impact of Quantum Battery Technology** In the quest for sustainable and efficient energy solutions, quantum battery technology...

**IQT Nordics Helsinki-Espoo 2024 Kicks Off Today – Inside Quantum Technology Reports** *Helsinki-Espoo, Finland – January 15, 2024* The much-anticipated...

**IQT Nordics Helsinki-Espoo 2024 Kicks Off Today – Inside Quantum Technology** The much-anticipated IQT Nordics Helsinki-Espoo 2024 conference officially kicks...

**Quantum News Highlights for June 25: Pioneering Advances and Strategic Partnerships** The quantum technology landscape is witnessing rapid advancements and...

# Quantum News Briefs June 25: Pioneering Advances in Quantum Technology The quantum technology landscape is rapidly evolving, with groundbreaking...

**Physicist Martin Freer Appointed Director of the UK’s Faraday Institution** In a significant development for the UK’s scientific community, physicist...

**Physicist Martin Freer Appointed Head of UK’s Faraday Institution for Battery Research** In a significant development for the field of...

**Physicist Martin Freer Appointed Head of UK’s Faraday Institution** In a significant development for the UK’s scientific community, physicist Martin...

**Investigating Dark Matter: Are WIMPs or Axions the Culprit? – Physics World** The universe is a vast and mysterious expanse,...

Physics World showcases groundbreaking brain imaging technology in SNMMI’s ‘Image of the Year’

Physics World recently highlighted a groundbreaking brain imaging technology that was showcased in the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) ‘Image of the Year’ competition. The winning image, titled “Mapping Neurotransmitter Release in the Brain,” was created using a cutting-edge imaging technique known as positron emission tomography (PET).

PET imaging is a non-invasive imaging technique that allows researchers to visualize and measure biochemical processes in the body, including the release of neurotransmitters in the brain. This technology is particularly valuable for studying neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and schizophrenia, as it provides insights into the underlying mechanisms of these conditions.

The winning image in the SNMMI competition was created by researchers at the University of California, Los Angeles (UCLA), who used PET imaging to map the release of dopamine in the brain. Dopamine is a neurotransmitter that plays a key role in regulating mood, motivation, and movement, and abnormalities in dopamine signaling have been implicated in a range of neurological and psychiatric disorders.

The researchers used a novel PET tracer called [18F]Fallypride to visualize dopamine release in the brains of healthy volunteers. By tracking the movement of this tracer in real-time, they were able to create a dynamic map of dopamine release in different regions of the brain. This groundbreaking technique provides valuable insights into how dopamine signaling is regulated in the brain and could lead to new treatments for disorders that involve dysregulation of dopamine pathways.

The ‘Image of the Year’ competition at SNMMI showcases the latest advances in nuclear medicine and molecular imaging, highlighting the innovative research being conducted in this field. The winning image from UCLA demonstrates the power of PET imaging to study complex biological processes in real-time, providing valuable information about brain function and dysfunction.

Overall, the groundbreaking brain imaging technology showcased in SNMMI’s ‘Image of the Year’ competition represents a significant advancement in our understanding of the brain and its role in health and disease. By harnessing the power of PET imaging, researchers are able to visualize and measure neurotransmitter release in unprecedented detail, opening up new possibilities for diagnosing and treating neurological disorders.